Focal/Grid Photocoagulation vs. Intravitreal Triamcinolone for Treatment of Diabetic Macular Edema

March 12, 2009

The March 2009 issue of The Archives of Ophthalmology contains a report on the 3-year outcomes of patients who participated in a randomized trial evaluating 1-mg and 4-mg doses of preservative-free intravitreal triamcinolone compared with focal/grid photocoagulation for treatment of diabetic macular edema.

Eyes with diabetic macular edema and visual acuities of 20/40 to 20/320 were randomly assigned to focal/grid photocoagulation or 1 mg or 4 mg of triamcinolone. At the conclusion of the trial, 3-year follow-up data were available in 306 eyes.

Results did not indicate a long-term benefit of intravitreal triamcinolone relative to focal/grid photocoagulation in patients with diabetic macular edema.

Read the full report.




Jump down to form below to submit your own comments

Comments are closed.